Table 1.
Cases of type 1 diabetes, DKA prevalence and standardised DKA prevalence, at type 1 diabetes diagnosis across the study population between 2006 and 2016
| Country | New diagnosis of type 1 diabetes (n) | DKA prevalence, % (95% CI) | Standardised DKA prevalence, % (95% CI)a |
|---|---|---|---|
| Australia (ADDN) | 4428 | 24.9 (23.6, 26.2) | 24.9 (23.4, 26.4) |
| Austria | 1504 | 38.0 (35.6, 40.5) | 37.7 (34.6, 40.7) |
| Czechia | 2261 | 28.8 (27.0, 30.7) | 28.6 (26.4, 30.8) |
| Denmark | 3084 | 20.7 (19.3, 22.1) | 20.8 (19.1, 22.4) |
| Germany | 19,127 | 26.8 (26.2, 27.4) | 26.8 (26.1, 27.5) |
| Italy | 10,317 | 41.2 (40.3, 42.2) | 41.2 (39.9, 42.4) |
| Luxembourg | 192 | 43.8 (36.9, 50.9) | 43.8 (34.5, 53.2) |
| New Zealand (Auckland) | 670 | 26.3 (23.1, 29.7) | 26.3 (22.4, 30.2) |
| Norway | 3331 | 22.1 (20.7, 23.5) | 22.1 (20.5, 23.7) |
| Slovenia | 471 | 40.3 (36.0, 44.8) | 39.9 (34.2, 45.6) |
| Sweden | 6457 | 19.5 (18.6, 20.5) | 19.5 (18.4, 20.6) |
| USA (SEARCH) | 5485 | 36.9 (35.6, 38.1) | 37.0 (35.4, 38.6) |
| UK (Wales) | 1673 | 25.0 (23.0, 27.2) | 25.0 (22.6, 27.4) |
| All countries combined | 59,000 | 29.2 (28.8, 29.6) |
aStandardised on whole study population